FREFresenius SE & Co. KGaA
39.07EUR+2.30%Mkt Cap: 21.85B EURP/E: 14.48Last update: 2026-05-14

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fr…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)14.48
P/E (Forward)9.95
PEG0.72
P/B1.10
P/S0.95
EV/EBITDA10.68
EV/Revenue1.41
EPS (TTM)2.68
EPS (Forward)3.90
Cash Flow & Leverage
FCF Yield8.26%
FCF Margin7.85%
Operating CF2.57B EUR
CapEx (TTM)1.50B EUR
Net Debt/EBITDA3.25
Net Debt9.85B EUR
Technical
SMA 5043.36 (-9.9%)
SMA 20046.94 (-16.8%)
Beta0.86
S&P 52W Chg24.23%
Avg Vol (30d)1.23M
Avg Vol (10d)1.53M
Technical Indicators
RSI (14)35.3
MACD-1.3731
MACD Signal-1.3050
MACD Hist.-0.0681
BB Upper44.57 EUR
BB Middle41.08 EUR
BB Lower37.60 EUR
BB Width16.97%
ATR (14)1.256 EUR
Vol Ratio (20d)1.10x
52W Range
38.166% of range52.96
52W High52.96 EUR
52W Low38.16 EUR
Profitability
Gross Margin24.89%
EBITDA Margin13.20%
Profit Margin5.53%
Oper. Margin10.22%
ROE6.62%
ROA3.05%
Revenue Growth2.00%
Earnings Growth90.00%
Balance Sheet
Debt/Equity0.62
Current Ratio1.26
Quick Ratio0.65
Book Value/Sh35.12 EUR
Cash/Share3.656 EUR
Dividends
Fwd Div Rate1.050 EUR
Trail. Div Rate1.050 EUR
Div. Yield2.71%
5Y Avg Yield1.15%
Payout Ratio37.31%
Ex-Div DateMay 25, 2026
Pay Date
Splits
Last Split3:1
Split DateAug 4, 2014
Ownership
Shares Out.563.24M
Float410.56M
Insiders27.01%
Institutions46.03%
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)55.08 EUR
Target Range48.00 EUR59.00 EUR
# Analysts14
Company
Market Cap21.85B EUR
Enterprise Value32.38B EUR
Revenue (TTM)22.99B EUR
Gross Profit5.69B EUR
Net Income (TTM)1.26B EUR
Revenue/Share40.81 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees177.8K
Last Price39.07 EUR
CountryDE
SectorHealthcare
IndustryMedical Care Facilities
ISINUS35804M1053